A Study of Experimental Medication BMS-986235 in Healthy Subjects

Inclusion Criteria: * Patients must be normal healthy volunteers as determined by no clinically significant deviations in medical history, physical examination, ECGs, vital signs, and clinical laboratory determinations * Patients must have a body mass index (BMI) of 18 - 30 mg/kg2, inclusive Exclusion Criteria: * Patients that are pregnant * Patient with any significant acute or chronic medical illness * Patient with a current or recent (within 3 months of study treatment administration) gastrointestinal disease that could affect absorption * Patient with any surgery within 12 weeks of study treatment administration * Patient with any gastrointestinal surgery that could impact upon the absorption of study drug * Patient who donated blood to a blood bank or in a clinical study (except a screening visit) within 12 weeks of study drug administration (within 2 weeks for plasma only) * Patient who received a blood transfusion within 12 weeks of study drug administration Other protocol defined inclusion/exclusion criteria apply